Search the site

Aboriginal Ear Health Stakeholder Meeting (By invitation only)

Acknowledging the enormous efforts in ear health programs across WA, we invite stakeholders to assist us in establishing research priorities.

Homes crucial for healthy ears

The Kids researchers discovered that overcrowding is the strongest predictor of carriage of bacteria that cause otitis media

DOWNLOAD - The first research report: Patterns and trends in Mortality in WA.

The Advisory Council on the Prevention of Deaths of Children and Young People today officially released this report.

Aboriginal researcher receives Fiona Stanley Medal

Aboriginal researcher Annette Stokes has been awarded the Fiona Stanley Medal for her commitment to improving child health and wellbeing.

Funding boost music to the ears of WA children

A $6 million commitment from Wesfarmers to Telethon will fund vital research to reduce the impact of chronic ear infections and other serious diseases.

Travelling with an ear infection

News you can use - Travelling with an ear infection

Ear health partnership brings brighter future for Aboriginal kids

A new partnership between The Kids Research Institute Australia, Dr George Sim and St John of God Murdoch Hospital will offer essential surgery at no cost for a group of Aboriginal children suffering severe ear infections.

The Kids ear health researcher takes out top science prize at 40Under40 Awards

Dr Chris Brennan-Jones received the Woodside STEM Award for Excellence in Science at the prestigious 40Under40 Awards.

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

In Australian remote communities, First Nations children with otitis media (OM)-related hearing loss are disproportionately at risk of developmental delay and poor school performance, compared to those with normal hearing. Our objective was to compare OM-related hearing loss in children randomised to one of 2 pneumococcal conjugate vaccine (PCV) formulations.

An infant mouse model of influenza-driven nontypeable Haemophilus influenzae colonization and acute otitis media suitable for preclinical testing of novel therapies

Nontypeable Haemophilus influenzae (NTHi) is a major otitis media (OM) pathogen, with colonization a prerequisite for disease development. Most acute OM is in children <5 years old, with recurrent and chronic OM impacting hearing and learning. Therapies to prevent NTHi colonization and/or disease are needed, especially for young children. Respiratory viruses are implicated in driving the development of bacterial OM in children.